Fidelity Investments’s CARGO Therapeutics CRGX Stock Holding History

Fidelity Investments’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,916,945	Closed	-$28.5M	–	5410
2025 Q2	$28.5M	Buy	6,916,945 +1,638,141	+31%	+$7.02M	﹤0.01%	1579
2025 Q1	$21.5M	Sell	5,278,804 -1,683,228	-24%	-$11.3M	﹤0.01%	1651
2024 Q4	$100M	Buy	6,962,032 +7,556	+0.1%	+$137K	0.01%	1119
2024 Q3	$128M	Buy	6,954,476 +77,508	+1%	+$1.39M	0.01%	993
2024 Q2	$113M	Buy	6,876,968 +696,197	+11%	+$13.2M	0.01%	1001
2024 Q1	$138M	Hold	6,180,771	–	–	0.01%	934
2023 Q4	$143M	Buy	+6,180,771	New	+$105M	0.01%	881

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fidelity Investments's CRGX Position: Q3 2025 in Review

Fidelity Investments sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 6,916,945 shares — an estimated $28.5M sold.

Fidelity Investments first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $143M in Q4 2023. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Fidelity Investments reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Fidelity Investments sold 6,916,945 CARGO Therapeutics shares in Q3 2025, an estimated $28.5M.
Fidelity Investments first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Fidelity Investments's CARGO Therapeutics position peaked at $143M in Q4 2023.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.